Zusammenfassung
Our previous studies indicated that lymphotoxin beta receptor (LT beta R) activation controls and downregulates inflammatory reactions. In this study, we report that LT beta R activation on primary mouse macrophages results in induction of tripartite motif containing (TRIM) 30 alpha, which negatively regulates NF-kappa B activation induced by TLR signaling. LT beta R activation results in a ...
Zusammenfassung
Our previous studies indicated that lymphotoxin beta receptor (LT beta R) activation controls and downregulates inflammatory reactions. In this study, we report that LT beta R activation on primary mouse macrophages results in induction of tripartite motif containing (TRIM) 30 alpha, which negatively regulates NF-kappa B activation induced by TLR signaling. LT beta R activation results in a downregulation of proinflammatory cytokine and mediator expression upon TLR restimulation, demonstrating that LT beta R signaling is involved in the induction of TLR cross-tolerance. Specific knockdown experiments using TRIM30 alpha-specific small interfering RNA abolished the LT beta R-dependent induction of TRIM30 alpha and LT beta R-mediated TLR cross-tolerance. Concordantly, LT beta R activation on bone marrow-derived macrophages induced cross-tolerance to TLR4 and TLR9 ligands in vitro. Furthermore, we have generated cell type-specific LT beta R-deficient mice with ablation of LT beta R expression on macrophages/neutrophils (LT beta R-flox/flox x LysM-Cre). In bone marrow-derived macrophages derived from these mice LT beta R-induced cross-tolerance to TLR4 and TLR9 ligands was impaired. Additionally, mice with a conditional ablation of LT beta R expression on macrophages (LT beta R flox/flox 3 LysM-Cre) are resistant to LT beta R-induced TLR4 tolerance in vivo. Collectively, our data indicate that LT beta R activation on macrophages by T cell-derived lymphotoxin alpha(1)beta(2) controls proinflammatory responses by activation of a TRIM30 alpha-controlled, counterregulatory signaling pathway to protect against exacerbating inflammatory reactions. The Journal of Immunology, 2012, 188: 3426-3433.